Clinical Trial Imaging Market: By Product & Services, By Modality, By End-User and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Clinical Trial Imaging Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product & Services (Software and Services), By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography and Other Modalities), By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes and Other End-Users) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Clinical Trial Imaging Market size was valued at US$ 1,386.2 million in 2023, is growing at a CAGR of 9.1% from 2024 to 2030. By product and services, the market has been segmented into Software and Services. The Services segment is likely to be the largest and fastest-growing segment in terms of products and services in 2022 and is expected to maintain the trend in the forecasted years sue to increasing spending in R & D sector and rapid growth in the pharmaceutical sector. Based on modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, and Other Modalities. Among these, the Computed Tomography segment is expected to have the fastest-growing market during the forecast period 2023-2029. It is attributed to increasing number of CROs, increase in research investments, and growth in pharma sector. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes and Other End-Users. The Pharmaceutical Companies segment accounts for the largest share in 2022 and is expected to maintain the trend in the forecasted years. However, high implementation cost of imaging systems and high capital required to run clinical trials are hindering the market growth. The market is predicted to rise due to the growing biotechnology and pharmaceutical sectors, as well as rising research and development investments for generating new pharmaceuticals to treat ailments.  

Clinical Trial Imaging Market Key Developments

  • In May 2021, IXICO Plc. (UK) signed a contract with biopharmaceutical client IXICO to provide neuroimaging services for a Phase III clinical trial under this contract.

summary download arrow Download Free Sample

Global Clinical Trial Imaging Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.9%

Largest Market

North-America

Fastest Growing Market

North-America

Clinical Trial Imaging Market Dynamics

Rising occurrence of chronic diseases such as Parkinson's and Alzheimer's and the rapidly growing geriatric population are anticipated to propel the market growth over the forecast years. The use of imaging in clinical trials is anticipated to increase due to an increase in imaging technology utilization and increased computational capacity.

Global Clinical Trial Imaging Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 1,386.2 million

Market CAGR

7.9%

By Product & Service

  • Software
  • Services
  • Operational Imaging Services
  • Read Analysis Services
  • System and Technical Support Services
  • Trial Design Consulting Services

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography
  • Other Modalities

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Research Organizations
  • Academic and Government Research Institutes
  • Other End-Users

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The clinical trial imaging market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global clinical trial imaging market size was valued at US$ 1,386.2 million in 2023, and is growing at a CAGR of 9.1% from 2024 to 2030.  

Emerging markets are expected to offer lucrative growth opportunities for market players in the upcoming years.

The high cost of the clinical trial and other associated cost are the major challenges in the market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Clinical Trial Imaging Market Introduction 
2.1.Global Clinical Trial Imaging Market  - Taxonomy
2.2.Global Clinical Trial Imaging Market  - Definitions
2.2.1.Product & Service
2.2.2.Modality
2.2.3.End User
2.2.4.Region
3.Global Clinical Trial Imaging Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Clinical Trial Imaging Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Clinical Trial Imaging Market  By Product & Service, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Software
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Services
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Operational Imaging Services
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Read Analysis Services
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. System and Technical Support Services
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Trial Design Consulting Services
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Clinical Trial Imaging Market  By Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Computed Tomography
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Magnetic Resonance Imaging
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ultrasound
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Positron Emission Tomography
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. X-Ray
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Echocardiography
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Other Modalities
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Clinical Trial Imaging Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Pharmaceutical Companies
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biotechnology Companies
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Medical Device Manufacturers
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Contract Research Organizations
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Academic and Government Research Institutes
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Other End-Users
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
8.Global Clinical Trial Imaging Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Clinical Trial Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product & Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Software
9.1.2.Services
9.1.3.Operational Imaging Services
9.1.4.Read Analysis Services
9.1.5.System and Technical Support Services
9.1.6.Trial Design Consulting Services
9.2.  Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Computed Tomography
9.2.2.Magnetic Resonance Imaging
9.2.3.Ultrasound
9.2.4.Positron Emission Tomography
9.2.5.X-Ray
9.2.6.Echocardiography
9.2.7.Other Modalities
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Pharmaceutical Companies
9.3.2.Biotechnology Companies
9.3.3.Medical Device Manufacturers
9.3.4.Contract Research Organizations
9.3.5.Academic and Government Research Institutes
9.3.6.Other End-Users
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Clinical Trial Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product & Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Software
10.1.2.Services
10.1.3.Operational Imaging Services
10.1.4.Read Analysis Services
10.1.5.System and Technical Support Services
10.1.6.Trial Design Consulting Services
10.2.  Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Computed Tomography
10.2.2.Magnetic Resonance Imaging
10.2.3.Ultrasound
10.2.4.Positron Emission Tomography
10.2.5.X-Ray
10.2.6.Echocardiography
10.2.7.Other Modalities
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Pharmaceutical Companies
10.3.2.Biotechnology Companies
10.3.3.Medical Device Manufacturers
10.3.4.Contract Research Organizations
10.3.5.Academic and Government Research Institutes
10.3.6.Other End-Users
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Clinical Trial Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product & Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Software
11.1.2.Services
11.1.3.Operational Imaging Services
11.1.4.Read Analysis Services
11.1.5.System and Technical Support Services
11.1.6.Trial Design Consulting Services
11.2.  Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Computed Tomography
11.2.2.Magnetic Resonance Imaging
11.2.3.Ultrasound
11.2.4.Positron Emission Tomography
11.2.5.X-Ray
11.2.6.Echocardiography
11.2.7.Other Modalities
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Pharmaceutical Companies
11.3.2.Biotechnology Companies
11.3.3.Medical Device Manufacturers
11.3.4.Contract Research Organizations
11.3.5.Academic and Government Research Institutes
11.3.6.Other End-Users
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Clinical Trial Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product & Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Software
12.1.2.Services
12.1.3.Operational Imaging Services
12.1.4.Read Analysis Services
12.1.5.System and Technical Support Services
12.1.6.Trial Design Consulting Services
12.2.  Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Computed Tomography
12.2.2.Magnetic Resonance Imaging
12.2.3.Ultrasound
12.2.4.Positron Emission Tomography
12.2.5.X-Ray
12.2.6.Echocardiography
12.2.7.Other Modalities
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Pharmaceutical Companies
12.3.2.Biotechnology Companies
12.3.3.Medical Device Manufacturers
12.3.4.Contract Research Organizations
12.3.5.Academic and Government Research Institutes
12.3.6.Other End-Users
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Clinical Trial Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product & Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Software
13.1.2.Services
13.1.3.Operational Imaging Services
13.1.4.Read Analysis Services
13.1.5.System and Technical Support Services
13.1.6.Trial Design Consulting Services
13.2.  Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Computed Tomography
13.2.2.Magnetic Resonance Imaging
13.2.3.Ultrasound
13.2.4.Positron Emission Tomography
13.2.5.X-Ray
13.2.6.Echocardiography
13.2.7.Other Modalities
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Pharmaceutical Companies
13.3.2.Biotechnology Companies
13.3.3.Medical Device Manufacturers
13.3.4.Contract Research Organizations
13.3.5.Academic and Government Research Institutes
13.3.6.Other End-Users
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Bioclinica, Inc.
14.2.2.Biomedical Systems Corporation
14.2.3.Biotelemetry, Inc.
14.2.4.Cardiovascular Imaging Technologies, LLC
14.2.5.Icon PLC
14.2.6.Intrinsic Imaging LLC
14.2.7.Ixico PLC
14.2.8.Parexel International Corporation
14.2.9.Radiant Sage LLC
14.2.10.Worldcare Clinical, LLC
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biotelemetry, Inc.
  • Cardiovascular Imaging Technologies, LLC
  • Icon PLC
  • Intrinsic Imaging LLC
  • Ixico PLC
  • Parexel International Corporation
  • Radiant Sage LLC
  • Worldcare Clinical, LLC

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market